Kilter Group’s Outset Medical OM Stock Holding History

Kilter Group’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-34	Closed	-$481	–	1463
2025 Q3	$481	Buy	+34	New	+$530	﹤0.01%	1064

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Kilter Group's OM Position: Q4 2025 in Review

Kilter Group sold out of Outset Medical (OM) in Q4 2025, closing a stake of 34 shares — an estimated $481 sold.

Kilter Group first reported a position in OM in Q3 2025 and held it in 1 quarter. The position peaked at $481 in Q3 2025. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

Kilter Group reported no remaining Outset Medical position as of Q4 2025 after selling out during the quarter.
Kilter Group sold 34 Outset Medical shares in Q4 2025, an estimated $481.
Kilter Group first reported a position in Outset Medical in Q3 2025 and held it in 1 quarter.
Kilter Group's Outset Medical position peaked at $481 in Q3 2025.
100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on Kilter Group's 13F filing for Q4 2025, filed 13 Feb 2026.